1.Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier.
Yurina MAESHIMA ; Kumiko OSETO ; Ryohei KATSURAGI ; Yukiko YOSHIMOTO ; Sachiko TAKAHARA ; Akira YAMAUCHI
Journal of Breast Cancer 2016;19(2):218-221
Women with BRCA1/2 mutations have a high risk of breast cancer and may opt for risk-reducing mastectomy (RRM). We report a 38-year-old Japanese woman who was diagnosed as a BRCA2 mutation carrier. She underwent prophylactic bilateral skin-sparing mastectomy (SSM) with excision of the nipple and preservation of the areola skin. It is unclear whether a bilateral RRM leads to better survival compared with intensive surveillance. The oncological risk associated with the presence of remnant breast glandular tissue after SSM or nipple-sparing mastectomy has been obscure. We report the first case of RRM for a Japanese BRCA mutation carrier and provide a literature review on risk management for BRCA mutation carriers with a focus on the concepts and procedures of RRM.
Adult
;
Asian Continental Ancestry Group
;
Breast
;
Breast Neoplasms
;
Female
;
Humans
;
Mastectomy*
;
Mastectomy, Subcutaneous
;
Nipples
;
Prophylactic Surgical Procedures
;
Risk Management
;
Skin
2.Endoscopic Ultrasound-Guided Tissue Acquisition by 22-Gauge Franseen and Standard Needles for Solid Pancreatic Lesions
Kazunaga ISHIGAKI ; Yousuke NAKAI ; Hiroki OYAMA ; Sachiko KANAI ; Tatsunori SUZUKI ; Tomoka NAKAMURA ; Tatsuya SATO ; Ryunosuke HAKUTA ; Kei SAITO ; Tomotaka SAITO ; Naminatsu TAKAHARA ; Tsuyoshi HAMADA ; Suguru MIZUNO ; Hirofumi KOGURE ; Minoru TADA ; Hiroyuki ISAYAMA ; Kazuhiko KOIKE
Gut and Liver 2020;14(6):817-825
Background/Aims:
Recently, a three-plane symmetric nee-dle with Franseen geometry was developed for endoscopic ultrasound-guided fine needle biopsy (EUS-FNB). In this ret-rospective study, tissue acquisition per pass was compared between 22-gauge Franseen FNB and standard fine needle aspiration (FNA) needles in patients with solid pancreatic le-sions.
Methods:
Consecutive patients who underwent EUSFNA or EUS-FNB for solid pancreatic lesions between Octo-ber 2014 and March 2018 were retrospectively studied. The tissue acquisition rate and the diagnostic performance per session, per pass, and at first pass were compared.
Results:
A total of 663 passes (300 by the FNB needle and 363 by the standard FNA needle) were performed in 154 patients (71 FNB and 83 FNA). The tissue acquisition rate per session and at first pass in the FNB and FNA groups was 100% and 95% (p=0.13) and 87% and 69% (p=0.007), respectively. The multivariate analysis revealed that among the patients, EUS-FNB (odds ratio, 3.07; p=0.01) was associated with a higher first-pass tissue acquisition rate. While the tissue ac-quisition rate reached a plateau after the 4th pass with FNA, it reached a plateau after the 2nd pass with FNB. Among the 129 malignant cases, the histological tissue acquisition rate per session was similar (100% and 94%), but the sensitivity by histology alone per session was higher for FNB than for FNA (93% and 73%, p<0.01).
Conclusions
The results of our retrospective analysis indicated that compared with a standard FNA needle, a 22-gauge Franseen FNB needle was associated with a higher first-pass tissue acquisition rate.